COG8 Gene Glycosylation disorder type 2H Genetic Test
Welcome to DNA Labs UAE, where we offer the COG8 Gene Glycosylation disorder type 2H Genetic Test. This test helps diagnose Congenital Disorder of Glycosylation type 2H (CDG2H), a glycosylation disorder associated with mutations in the COG8 gene.
Test Details
The COG8 gene is responsible for the formation of the conserved oligomeric Golgi (COG) complex, which plays a crucial role in the process of glycosylation. Glycosylation is the attachment of sugar molecules to proteins and lipids. Mutations in the COG8 gene can disrupt this process, leading to CDG2H.
Our NGS Technology-based genetic testing allows for the comprehensive analysis of the COG8 gene, identifying any mutations or variants that may be present. This testing method analyzes multiple genes simultaneously, providing a thorough evaluation of genetic variations associated with CDG2H.
Test Components and Price
The COG8 Gene Glycosylation disorder type 2H Genetic Test is priced at 4400.0 AED.
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on an FTA Card for this test.
Report Delivery
After the sample is received, the report will be delivered within 3 to 4 weeks.
Test Type
This test falls under the category of Metabolic Disorders.
Doctor and Test Department
This test can be ordered by a General Physician and falls under the Genetics department.
Pre Test Information
Prior to the test, we recommend providing the clinical history of the patient who is undergoing the COG8 Gene Glycosylation disorder type 2H NGS Genetic DNA Test. Additionally, a Genetic Counselling session is advised to draw a pedigree chart of family members affected by Glycosylation disorder type 2H.
Conclusion
NGS genetic testing for COG8 gene mutations is a valuable tool in diagnosing CDG2H and understanding the underlying cause of the disorder. This information can guide treatment decisions and provide genetic counseling for affected individuals and their families.
| Test Name | COG8 Gene Glycosylation disorder type 2H Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for COG8 Gene Glycosylation disorder type 2H NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 2H |
| Test Details |
The COG8 gene is associated with a glycosylation disorder called Congenital Disorder of Glycosylation type 2H (CDG2H). This disorder affects the process of glycosylation, which is the attachment of sugar molecules to proteins and lipids. CDG2H is caused by mutations in the COG8 gene, which is involved in the formation of the conserved oligomeric Golgi (COG) complex. Next-generation sequencing (NGS) genetic testing can be used to analyze the COG8 gene and identify any mutations or variants that may be present. This type of genetic testing allows for the simultaneous analysis of multiple genes, providing a comprehensive evaluation of genetic variations that may be associated with CDG2H. NGS genetic testing for COG8 gene mutations can help in the diagnosis of CDG2H and provide information about the specific genetic changes involved. This can aid in understanding the underlying cause of the disorder and may guide treatment decisions and genetic counseling for affected individuals and their families. |
